In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Marie-Julie Nokin, Elodie Darbo, Elodie Richard, Sonia San José, Sergio de Hita, Valérie Prouzet-Mauleon, Béatrice Turcq, Laura Gerardelli, Rebekah Crake, Valérie Velasco, Benjamin Koopmansch, Frederic Lambert, Jenny Y. Xue, Ben Sang, Julie Horne, Eric Ziemons, Alberto Villanueva, Arnaud Blomme, Michael Herfs, Didier Cataldo, Olivier Calvayrac, Paolo Porporato, Ernest Nadal, Piro Lito, Pasi A.

Journal title: Cell Reports Medicine

Journal number: 5

Journal publisher: Elsevier

Published year: 2024

Published pages: 101663

DOI identifier: 10.1016/j.xcrm.2024.101663

ISSN: 2666-3791